OverviewChartNewsTraderScreen

Citi Call 170 PGR 20.06.2024/  DE000KH8JY51  /

Frankfurt Zert./CITI
2024-04-09  9:29:15 AM Chg.-0.060 Bid3:00:51 PM Ask- Underlying Strike price Expiration date Option type
4.010EUR -1.47% -
Bid Size: -		 -
Ask Size: -		 Progressive Corporat... 170.00 - 2024-06-20 Call
GlobeNewswire 05-09 Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...
GlobeNewswire 05-09 Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...
GlobeNewswire 05-08 Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...
GlobeNewswire 05-07 MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...
GlobeNewswire 05-06 Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire 05-04 The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats
GlobeNewswire 05-02 PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...
GlobeNewswire 05-01 Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire 05-01 Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 ...
GlobeNewswire 05-01 Opthea Announces Upcoming Presentations at the Retina World Congress 2024
GlobeNewswire 05-01 Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evalu...
GlobeNewswire 05-01 TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 04-30 Progressive Announces Investor Relations Call
GlobeNewswire 04-25 Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Re...
GlobeNewswire 04-25 Opthea to Present at the OIS Retina Innovation Summit at ARVO
TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 04-24 Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society...
TeleTrader 04-23 Biden meets AOC amid divide on Israel policy
GlobeNewswire 04-22 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...
GlobeNewswire 04-22 Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients i...
GlobeNewswire 04-19 Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Scleros...
GlobeNewswire 04-18 Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with B...
GlobeNewswire 04-18 TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple ...
GlobeNewswire 04-18 Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting...
GlobeNewswire 04-18 TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the P...